181811-46-1 Usage
Description
1-(1,3-Benzoxazol-2-yl)piperidine-4-carboxylic acid is a chemical compound that belongs to the piperidine class of compounds. It is characterized by a piperidine ring with a benzoxazole group attached to it, which contributes to its potential pharmacological properties. This chemical compound is of interest in the field of medicinal chemistry due to its diverse biological activities and the presence of the piperidine-4-carboxylic acid moiety, a common structural element in pharmaceutical compounds.
Uses
Used in Medicinal Chemistry:
1-(1,3-Benzoxazol-2-yl)piperidine-4-carboxylic acid is used as a building block or precursor for the synthesis of pharmaceuticals and agrochemicals. Its unique structure, which includes a benzoxazole group and a piperidine-4-carboxylic acid moiety, makes it a potentially valuable tool in drug discovery and development.
Used in Drug Discovery and Development:
In the pharmaceutical industry, 1-(1,3-Benzoxazol-2-yl)piperidine-4-carboxylic acid is used as a key component in the development of new drugs. Its diverse biological activities and the presence of the piperidine-4-carboxylic acid moiety make it a promising candidate for the creation of novel therapeutic agents.
Used in Agrochemicals:
1-(1,3-Benzoxazol-2-yl)piperidine-4-carboxylic acid is also utilized as a building block or precursor in the synthesis of agrochemicals. Its potential pharmacological properties and unique structure contribute to the development of new compounds for use in agriculture, such as pesticides and herbicides.
Check Digit Verification of cas no
The CAS Registry Mumber 181811-46-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,1,8,1 and 1 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 181811-46:
(8*1)+(7*8)+(6*1)+(5*8)+(4*1)+(3*1)+(2*4)+(1*6)=131
131 % 10 = 1
So 181811-46-1 is a valid CAS Registry Number.
181811-46-1Relevant articles and documents
CASPASE INHIBITOR AND PHARMACEUTICAL COMPOSITION, USE AND THERAPEUTIC METHOD THEREOF
-
Paragraph 0566; 0568, (2019/04/05)
Disclosed are a class of compounds as a caspase inhibitor, and in particular the compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, and the use of the compound in treating caspase-related diseases.
